Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: Moderate Risk
2C-B carries a moderate risk profile. Acute and chronic risks depend significantly on dose, frequency, route of administration, and individual predispositions.
The following substances carry an elevated risk of adverse interactions with 2C-B. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
dosing
Niedrig einsteigen: 10–15 mg oral für Erstanwender, nicht direkt zu 20+ mg
dosing
Nüchtern konsumieren — Essen verlangsamt den Wirkungseintritt stark und erhöht Übelkeitsrisiko
setting
Set & Setting: ruhige, vertraute Umgebung, besonders bei Dosen über 20 mg
setting
Tripsitter bei höheren Dosen (>20 mg) empfehlenswert, insbesondere bei Unerfahrenen
combinations
Keine Kombination mit Lithium (Krampfrisiko) oder MAO-Hemmern
combinations
Vorsicht bei Kombination mit MDMA (5-HT2A-Desensibilisierung beeinträchtigt 2C-B-Wirkung, Cardiotoxizität)
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.